Carboplatin Calculator

The Carboplatin Calculator estimates carboplatin dose. Simply enter your target AUC and GFR to calculate your carboplatin dose in milligrams and adjusted clearance. This tool provides an estimate of the drug amount based on kidney function and desired drug exposure. This calculator also calculates adjusted clearance.

Enter the desired area under the curve (e.g., 5 for standard dosing)
Enter the patient's GFR value (e.g., 60 for moderate kidney function)

This calculator is a screening tool only, not a diagnostic instrument. It is not intended to replace professional medical evaluation. Consult a healthcare provider.

What Is Carboplatin Dose

Carboplatin dose is the amount of carboplatin medicine given to a patient in milligrams. Carboplatin is a type of chemotherapy drug used to treat several kinds of cancer. The dose is not the same for everyone. It is based on how well the patient's kidneys work and how strong the drug effect should be. Getting the right dose helps make sure the treatment works well while limiting side effects.

How Carboplatin Dose Is Calculated

Formula

Dose (mg) = Target AUC x (GFR + 25)

Where:

  • Dose = total carboplatin dose in milligrams (mg)
  • Target AUC = desired area under the concentration-time curve (mg/mL·min)
  • GFR = glomerular filtration rate, a measure of kidney function (mL/min)
  • 25 = estimated non-renal clearance of carboplatin (mL/min)

This formula is called the Calvert formula. It works by first adding a fixed number, 25, to the patient's GFR. That extra 25 accounts for the fact that some carboplatin leaves the body through ways other than the kidneys. The total of GFR plus 25 is called the adjusted clearance. Then, that total is multiplied by the target AUC. The AUC is a number that represents how much of the drug should be in the body over time. A higher AUC means a stronger treatment effect. The final answer is the dose in milligrams.

Why Carboplatin Dose Matters

Knowing the right carboplatin dose helps make sure the treatment plan fits each patient. Since the drug leaves the body mostly through the kidneys, a person's kidney function has a large effect on the dose they may receive.

Why Accurate Dosing Is Important for Cancer Treatment

If the dose is too high, a patient may experience more severe side effects such as low blood cell counts, which can lead to infections or bleeding. If the dose is too low, the treatment may not be as effective against the cancer. The Calvert formula helps find a middle ground by matching the dose to each person's kidney function, though individual responses may still vary.

For First-Line Chemotherapy

When carboplatin is used as the main treatment for a newly diagnosed cancer, doctors may aim for a higher AUC value. This is because the goal is to have a strong treatment effect right away. A typical target AUC in this case may be around 5 to 7, depending on the type of cancer and other factors specific to the patient.

For Maintenance or Palliative Therapy

When the goal is to control the cancer or ease symptoms over a longer period, a lower AUC target may be used. This approach may help reduce side effects while still providing benefit. A target AUC of 4 to 5 is commonly considered in these situations, though the exact number depends on many patient factors.

For Elderly Patients

Older adults often have lower kidney function even if they do not have kidney disease. This means their GFR may be lower, which leads to a lower carboplatin dose using this formula. Doctors may also choose a lower AUC target for older patients to reduce the chance of severe side effects, since older bodies may handle chemotherapy differently.

Example Calculation

Consider a patient with moderate kidney function whose GFR is 60 mL/min. The doctor has chosen a target AUC of 5 mg/mL·min for standard oncology dosing. These two values are entered into the calculator.

First, the calculator adds 25 to the GFR: 60 + 25 = 85 mL/min. This is the adjusted clearance. Then, it multiplies the adjusted clearance by the target AUC: 5 x 85 = 425 mg.

Carboplatin Dose: 425 mg | Adjusted Clearance: 85 mL/min

This result means the estimated dose is 425 milligrams of carboplatin. A healthcare provider may use this estimate to prepare the treatment and would consider the patient's full health picture before giving the final dose. The actual dose given may be adjusted based on other factors not included in this formula.

Frequently Asked Questions

What is a normal target AUC for carboplatin?

A target AUC between 4 and 7 is commonly used in cancer treatment. The exact number depends on the type of cancer, whether it is the first round of treatment, and the patient's overall health. A doctor chooses the AUC based on treatment guidelines and the patient's specific situation.

How often should carboplatin dosing be recalculated?

Carboplatin dosing is commonly recalculated before each treatment cycle. Kidney function can change over time, especially during chemotherapy. Checking GFR before each dose helps make sure the amount stays appropriate as the patient's body changes during treatment.

Does this formula work for children?

The Calvert formula was developed and studied mainly in adults. Pediatric dosing of carboplatin often uses different methods that account for body surface area and age-related kidney development. This calculator is not designed for use in children, and a pediatric oncologist should determine the appropriate dose.

Can I use this calculator if I have severe kidney disease?

This calculator uses a standard formula that may not fully account for the complexities of severe kidney impairment. Patients with very low GFR values may need specialized dosing approaches. A healthcare provider familiar with the patient's medical history should determine the most appropriate dose in these cases.

References

  • Calvert AH, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. Journal of Clinical Oncology. 1989;7(11):1748-1756.
  • Egorin MJ, et al. Pharmacokinetics of carboplatin and prediction of its disposition using creatinine clearance or EDTA clearance. Cancer Chemotherapy and Pharmacology. 1990;25(4):263-267.
  • National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. Version 2.2024.

Calculation logic verified using publicly available standards.

View our Accuracy & Reliability Framework →